A few articles from the stack I've created. It's a way to gently open the firehose of information and articles that come across our desks each week.
Our ability to forget provides a survival advantage – while assuaging suffering in the process.
President Donald Trump completed his first periodic medical examination at Walter Reed National Military Medical Center. His White House physician, Rear Adm. Ronny Jackson, released a statement of his findings and held a protracted press conference. His conclusions discussed here.
Too much, too little, and just the right amount of sleep have been linked to death. Sorry.
In the fight against Alzheimer's, memory loss has kept its place as the frontrunner of early warning signs, but that may no longer hold true.
Pregnant women are advised to avoid cat litter boxes — so they don't get infected with Toxoplasmosis gondii, which can cause birth defects. Recent research also suggests that this parasite may also be linked to neurodegenerative diseases such as Parkinson's and Alzheimer's.
While we often pooh-pooh the claims of marketers for the efficacy of dietary supplements, we're not blind to the possibilities. One supplement that has been studied in transgenic growth hormone (or TGM) mice may hold promise for treating or staving off neuro-degenerative diseases such as Alzheimer's. More work is needed, of course.
In a surprising report, researchers using data from the long-term Framingham, MA study have shown that the age-specific incidence of new cases of dementia have actually fallen by 44 percent since 1977. The number of overall new cases, however, will continue to rise as the population ages.
A.D.H.D., once thought of as a disorder that affects only children and young adults, may not fade nor disappear in adulthood, which is why a doctor at Johns Hopkins believes it may affect the elderly as well.
The latest in health this week: Amino acids key in Alzheimer's may develop 20 to 30 years prior to onset of illness, the March Against Myths of Modification needs your help in debunking the dangers of GMOs, and Metabolic Syndrome affects one in every three US adults
Last week we wrote about Jane Brody s New York Times article on solutions for cognitive decline. And this week, she covers cognitive decline once again, this time focusing on different tests for early signs of dementia.
A new paper published in JAMA Internal Medicine makes an interesting claim that a class of drugs called anticholinergics may cause dementia and Alzheimer s disease.